DR ERWIN DENIES
ActiveSummary
DR ERWIN DENIES has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €506,142 and a net result of €248,532. The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
- Equity
- €506,142
- Profit
- €248,532
Why 98raises riskFounded in 2023lowers riskSize: total assets €588,254Liquidity: current ratio 7.16, cash €557,524No main activity registeredShow the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 88% on liquidity, 90% on profitability and 92% on growth.
The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 2 accounts on average 20 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Appointment: Ilse NEDERGEDAELT (mede bestuurder)Gazette deed
- Equity above €500,000equity €506,142 ▲96.5%
Financials · financial year 2025, micro format
2024 to 2025, 2 financial years
The operating result falls in 2025; 2025 is 2% below 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
Peer companies
Historical observationOf the 3,127 companies that looked in July 2024 the way this one looks now, 0.8% went bankrupt within 24 months and 97.2% are still going.
- Small
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 3,127 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Other operating charges640/8 | €1,052 | €673 | ▼ 36.0% |
| Gross operating margin9900 | €334,589 | €327,094 | ▼ 2.2% |
| Operating profit (loss)9901 | €333,537 | €326,421 | ▼ 2.1% |
| Financial income75/76B | €16 | €0 | ▼ 100% |
| Recurring financial income75 | €16 | €0 | ▼ 100% |
| Financial charges65/66B | €44 | €797 | ▲ 1,733% |
| Recurring financial charges65 | €44 | €797 | ▲ 1,733% |
| Profit (loss) for the period before taxes9903 | €333,510 | €325,624 | ▼ 2.4% |
| Income taxes67/77 | €78,899 | €77,092 | ▼ 2.3% |
| Profit (loss) for the period9904 | €254,610 | €248,532 | ▼ 2.4% |
| Profit (loss) for the period to be appropriated9905 | €254,610 | €248,532 | ▼ 2.4% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €269,082 | €588,254 | ▲ 119% |
| Current assets29/58 | €269,082 | €588,254 | ▲ 119% |
| Amounts receivable within one year40/41 | €16,101 | €29,401 | ▲ 82.6% |
| Other amounts receivable41 | €16,101 | €29,401 | ▲ 82.6% |
| Cash at bank and in hand54/58 | €247,351 | €557,524 | ▲ 125% |
| Deferred charges and accrued income490/1 | €5,630 | €1,329 | ▼ 76.4% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €269,082 | €588,254 | ▲ 119% |
| Equity10/15 | €257,610 | €506,142 | ▲ 96.5% |
| Contributions10/11 | €3,000 | €3,000 | = |
| Profit (loss) carried forward14 | €254,610 | €503,142 | ▲ 97.6% |
| Amounts payable17/49 | €11,471 | €82,112 | ▲ 616% |
| Amounts payable within one year42/48 | €11,471 | €82,112 | ▲ 616% |
| Trade debts44 | €6,894 | €3,336 | ▼ 51.6% |
| Suppliers440/4 | €6,894 | €3,336 | ▼ 51.6% |
| Taxes, remuneration and social security45 | €720 | €78,776 | ▲ 10,838% |
| Taxes450/3 | €720 | €77,092 | ▲ 10,604% |
| Remuneration and social security454/9 | - | €1,684 | - |
| Other amounts payable47/48 | €3,858 | €0 | ▼ 100% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €254,610 | €248,532 | ▼ 2.4% |
| Operating cash flow (approximation) | €254,610 | €248,532 | ▼ 2.4% |
| Change in cash | - | €310,173 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (2)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 29-06-2026 | 2026-00214543 |
| 31-12-2024 | micro format | 23-07-2025 | 2025-00299128 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| DENIES Erwin Hendrik |
|
| Ilse NEDERGEDAELT |
|
Owners and capital
Capital and shareholders
- DENIES Erwin Hendrik 100 shares (100%) · €3,000
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 11-12-2023 Incorporation · €3,000 · 100 shares
Group and network
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
DR ERWIN DENIES was incorporated on 7 December 2023 as a private limited company by one natural person, with a starting capital of €3,000.12 The board currently has 2 members; DENIES Erwin Hendrik has served longest, since 2023.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Acts, filings and financial milestones
28-01
Gazette deed
Appointment: Ilse NEDERGEDAELT (mede bestuurder)5 facts ▸
- General meeting, 17-12-2025
- Director appointment, Ilse NEDERGEDAELT (mede bestuurder)
- Board composition, Erwin DENIES (director)
- Board composition, Ilse NEDERGEDAELT (mede bestuurder)
- Other provision, “aanvaarding mandaat” (deed in Dutch)
11-12
Gazette deed
IncorporationAppointment: DENIES Erwin Hendrik (director) · Founder · Founding capital7 facts ▸
- Incorporation, 06-12-2023
- Founder, DENIES Erwin Hendrik
- Founding capital, €3,000
- Registered office clause, “1560 Hoeilaart,J.B.Blommaertstraat 8” (deed in Dutch)
- Pre-incorporation commitments, “takeover, rechten en verbintenissen uit rechtshandelingen in naam en voor rekening voor oprichting” (deed in Dutch)
- Director appointment, DENIES Erwin Hendrik (director)
- Other provision, “afwezigheid beroepsverbod, geen beroepsverbod uitgesproken” (deed in Dutch)
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 23 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 23033B0507/00P006 | Flanders | 552 m² | 1 · 146 m² | 9.9 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het ter beschikking stellen van alle nodige middelen aan de arts/artsen die tot de vennootschap zijn toegetreden: het inrichten van de…” (deed in Dutch)
10 activities (deed in Dutch)
- Het ter beschikking stellen van alle nodige middelen aan de arts/artsen die tot de vennootschap zijn toegetreden: het inrichten van de praktijk voor de geneeskunde; de uitvoering van technische, medische, radiografische en laboratoriumprestaties (facultatief gezien niet steeds van toepassing), het inrichten van algemene diensten en een medisch secretariaat in het bijzonder, die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten, het aanleggen van reserves ten einde alle nodige apparaten en gebouwen aan te schaffen, nodig of nuttig om voormeld voorwerp te bereiken;
- De mogelijkheid scheppen om de arts-aandeelhouder(s) toe te laten zich verder te bekwamen ten einde in hun discipline aan de spits van de evolutie te blijven.
- 1. het verstrekken van medische adviezen en raadgevingen.
- 2. het inrichten van algemene diensten en het ter beschikking stellen van de ruimten, die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten, met inbegrip van een medisch secretariaat.
- 3. de aankoop, het huren en het ter beschikking stellen van alle medische apparatuur, machines en bibliotheek, die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten.
- 4. het bevorderen van de medische studie en de mogelijkheden scheppen om de arts-aandeelhouder toe te laten zich verder te bekwamen teneinde in zijn discipline bij te blijven.
- 5. het aanleggen van reserves om daarmee alle materiële infrastructuur (apparaten en gebouwen) aan te schaffen, die nodig of nuttig zijn om de geneeskunde uit te oefenen.
- 6. de vennootschap kan, met het oog op een professionele samenwerking, overeenkomsten afsluiten met artsen of (kosten)associaties, professionele (eenpersoons)vennootschappen, middelenvennootschappen en verenigingen zonder winstoogmerk.
- 7. de vennootschap kan aandeelhouder zijn van een (kosten)associatie of middelenvennootschap van artsen en kan lid zijn van een vereniging zonder winstoogmerk van artsen.
- De vennootschap kan eveneens optreden als bestuurder, zaakvoerder, volmachtdrager, mandataris of vereffenaar in andere vennootschappen of ondernemingen, mits naleving van artikel 2:55 van het Wetboek van vennootschappen en verenigingen.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- DR ERWIN DENIES
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Indien de vennootschap door meer dan één bestuurders wordt bestuurd, mag iedere bestuurder, alleen optredend, alle handelingen stellen die…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Een of meer, Benoeming-Ontslag” (deed in Dutch)“Bestuur-bevoegdheden, alle handelingen nodig of dienstig tot verwezenlijking voorwerp” (deed in Dutch)“1” (deed in Dutch)1 more provision on this in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Op naam, 100” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Friday of June at 18:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Ontbinding, algemene vergadering” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Bestuurders in functie van rechtswege vereffenaars jegens derden, ontbinding en vereffening in één akte” (deed in Dutch)1 more provision on this in the deed